Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG CureVac - 11 Mar 2020 Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG ... More
Why is Ingmar Hoerr, Co-Founder & CEO of CureVac, reading Labiotech.eu? Labiotech.eu - 22 Jun 2022 Why is Ingmar Hoerr, Co-Founder & CEO of CureVac, reading Labiotech.eu? ... More
Gleiss Lutz advises founder and shareholder Dr. Ingmar Hoerr in connection with CureVac’s IPO on the New York stock exchange Nasdaq Gleiss Lutz - 11 Aug 2020 Gleiss Lutz advises founder and shareholder Dr. Ingmar Hoerr in connection with CureVac’s IPO on the New York stock exchange Nasdaq ... More
The tangled history of mRNA vaccines Nature.com - 14 Sep 2021 The tangled history of mRNA vaccines ... More
Was it something he said? Biotech CEO who met Trump this month exits without a word Fierce Biotech - 12 Mar 2020 Was it something he said? Biotech CEO who met Trump this month exits without a word ... More
The Race Is On: What mRNA Product Will Reach the Market First? Genetic Engineering & Biotechnology News - 07 Feb 2019 The Race Is On: What mRNA Product Will Reach the Market First? ... More
How vaccine laggard CureVac hopes to come out on top Financial Times - 22 Feb 2021 How vaccine laggard CureVac hopes to come out on top ... More
CureVac Provides Supervisory Board Update CureVac - 23 Jun 2021 CureVac Provides Supervisory Board Update ... More
Phase II Failure: CureVac’s CEO explains Missed Efficacy Endpoint Labiotech.eu - 17 Feb 2023 Phase II Failure: CureVac’s CEO explains Missed Efficacy Endpoint ... More
CureVac's lead mRNA drug is down but not out, says CEO Fierce Biotech - 12 Jan 2017 CureVac's lead mRNA drug is down but not out, says CEO ... More
Kampf gegen Corona: Curevac: Patente für Impfstoffe aussetzen Stuttgarter Zeitung - 16 Dec 2020 Kampf gegen Corona: Curevac: Patente für Impfstoffe aussetzen ... More
Bill & Melinda Gates’ Faith in CureVac is Leading to a New Program Labiotech.eu - 21 Jun 2022 Bill & Melinda Gates’ Faith in CureVac is Leading to a New Program ... More